MicroRNAs in Acute COVID-19 and Long COVID: Dysregulation, Pathogenic Roles, and Clinical Implications.
Article Title: MicroRNAs in Acute COVID-19 and Long COVID: Dysregulation, Pathogenic Roles, and Clinical Implications.
PMID: 42028925
Plain-Language Summary
MicroRNAs (miRNAs) are small molecules that control gene expression. They play vital roles in immune responses and viral infections. Studies show that infection with the SARS-CoV-2 virus, which causes COVID-19, leads to significant changes in miRNA levels in both the body and the virus. These changes contribute to the severity of acute COVID-19 and the persistent symptoms seen in long COVID (LC). This review examines current research on miRNA changes during and after COVID-19, emphasizing their roles in disease development and possible use as therapeutic targets.
Research indicates that during acute COVID-19, altered miRNA profiles reflect the body's immune responses and the virus's efforts to evade the immune system. In long COVID, ongoing changes in miRNAs are linked to unresolved inflammation, lung problems, neurological issues, and blood vessel damage. While miRNAs show promise as markers for COVID-19, more studies are needed to fully understand their impact and potential for treating post-acute symptoms.
Key Findings
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to significant dysregulation of microRNAs, impacting disease severity in acute COVID-19 and contributing to persistent symptoms in long COVID.
- Altered microRNA profiles during acute infection reflect both the body's responses and viral immune modulation strategies, while persistent miRNA changes in long COVID are associated with continued inflammation and organ damage.
- MicroRNAs hold promise as biomarkers and therapeutic targets in COVID-19, but further research is crucial to understand their exact roles in disease progression and potential treatment strategies.
Study Type
Review article
What This Means (and Doesn’t Mean)
Understanding how microRNAs are dysregulated in acute and long COVID provides valuable insights into disease mechanisms and potential therapeutic targets. The findings suggest that monitoring microRNA changes could aid in diagnosing and managing COVID-19 patients effectively. However, the study's observational nature and limited available data emphasize the need for more in-depth, longitudinal studies to confirm these findings and explore the clinical applications of microRNAs in COVID-19 further.
While the research highlights the importance of microRNAs in COVID-19 pathogenesis, it is essential to acknowledge the study's limitations, such as the variability in existing data and the necessity for more comprehensive investigations to establish causality and treatment strategies based on microRNA regulation.
Source
Disclaimer
This summary was created with the assistance of artificial intelligence and reviewed by a human prior to publication. While care is taken to ensure accuracy, errors are possible. If you notice any issues, have questions, or would like to request coverage of a specific research paper, please contact admin@long-covid.org.
Share
If you found this summary helpful, please consider sharing it. It helps more people find clear, trustworthy Long COVID research.
Article Excerpt
MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression with central roles in immune responses, inflammation, and viral pathogenesis.